Platelet aggregation in severe sepsis

Area of Science:

• Critical Care Medicine
• Hematology
• Pathophysiology

Background:

• Severe sepsis and multiple organ dysfunction syndrome present significant diagnostic and therapeutic challenges.
• Platelet activating factor links inflammation and thrombosis, crucial in sepsis pathophysiology.
• Understanding sepsis's impact on platelet function is vital for managing critically ill patients.

Purpose of the Study:

• To investigate the effects of severe sepsis on platelet function, specifically spontaneous aggregation.
• To compare platelet aggregation in septic patients with healthy controls.
• To assess the relationship between platelet function, clinical status (MODS, SOFA), and patient outcomes.

Main Methods:

• Collected daily arterial blood samples from 45 severe sepsis patients over five days and 30 healthy controls.
• Measured platelet aggregation using adrenaline (ADR), adenosine diphosphate (ADP), and collagen (COL).
• Assessed clinical status using Multiple Organ Dysfunction Score (MODS) and Sequential Organ Failure Assessment (SOFA) scores.

Main Results:

• Inducible platelet aggregation with ADR, ADP, and COL significantly deteriorated in septic patients throughout the study period (P < 0.05).
• Patients with low platelet counts exhibited weaker inducible aggregation across various agonists.
• Spontaneous platelet activity was present in septic patients, but inducible aggregation did not predict survival.

Conclusions:

• Severe sepsis is characterized by impaired inducible platelet aggregation and the presence of spontaneous platelet activity.
• Platelet count influences inducible aggregation, but overall platelet function does not predict outcomes in severe sepsis.
• Further research into spontaneous platelet activity in sepsis may offer new therapeutic insights.